15 September 2026


Looking for some essential rheumatology reading? Rheumatology has now published nine commissioned reviews exploring a range of important and emerging topics across the specialty.

Commissioned by Editor-in-Chief Ernest Choy and the journal’s Co-Editors, the collection brings together global experts to examine high-impact areas of rheumatology research and clinical practice.

Whether you are catching up on the latest developments or looking to explore a particular area in more depth, here are nine reviews to add to your reading list.

JAK inhibitors beyond inflammatory arthritis

JAK inhibitors in areas outside of inflammatory arthritis: focus on connective tissue diseases
Carlo Perricone et al.

Explore the use of JAK inhibitors beyond inflammatory arthritis, with a particular focus on connective tissue diseases.

Read the review


The future of glucocorticoid treatment

Novel glucocorticoids: current status and challenges
Frank Buttgereit and Christopher J Edwards

An exploration of novel glucocorticoids, their current status and the challenges surrounding their development and use.

Read the review


Targeting fibroblasts in inflammatory disease

Targeting fibroblasts in immune mediated inflammatory diseases: a cellular basis for cure?
Mikalena Xenophontos et al.

This review considers fibroblasts as a therapeutic target across immune-mediated inflammatory diseases.

Read the review


Synovial biopsy in rheumatoid arthritis

Synovial biopsy and tissue sampling in the management of RA
Elisa Gremese et al.

Explore the role of synovial biopsy and tissue sampling in the management of rheumatoid arthritis.

Read the review


Treatment choices in axial spondyloarthritis

Choosing treatment and targeted therapy in axial spondyloarthritis
Kalliopi Klavdianou and Xenofon Baraliakos

A review focused on treatment selection and targeted therapies in axial spondyloarthritis.

Read the review


Rheumatic drugs in paediatric and adolescent care

The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care
Coziana Ciurtin et al.

Explore the changing landscape of rheumatic drug treatments and their indications for children and young people.

Read the review


Biomarkers in lupus nephritis

Current perspectives on biomarkers to safely guide reduction and withdrawal of immunosuppressants in lupus nephritis
Anna Henning et al.

This review looks at the potential role of biomarkers in guiding the safe reduction and withdrawal of immunosuppressive treatment in lupus nephritis.

Read the review


Digital vasculopathy in systemic sclerosis

Assessing digital vasculopathy in systemic sclerosis
Ariane L Herrick

An overview of approaches to assessing digital vasculopathy in systemic sclerosis.

Read the review


Monogenic autoimmune and autoinflammatory disorders

Monogenic autoimmune and autoinflammatory disorders in adulthood: recent discoveries and implications for rheumatology practice
Yiming Luo et al.

Explore recent discoveries in monogenic autoimmune and autoinflammatory disorders in adulthood and their implications for rheumatology practice.

Read the review


Have an idea for a future review?

The Rheumatology editorial team welcomes proposals for future commissioned reviews. If there is an important or emerging topic you think the journal should consider, email us with your proposal.